PAK4

PAK4

A gene on chromosome 19q13.2 that encodes a PAK protein of the serine/threonine p21-activating kinase family, which serve as targets for the small GTP-binding proteins Cdc42 and RAC and have been implicated in a wide range of biological activities. PAK4 interacts specifically with the GTP-bound form of Cdc42Hs and weakly activates the JNK family of MAP kinases; it mediates filopodia formation and may play a role in reorganising the actin cytoskeleton.
References in periodicals archive ?
Karyopharm Therapeutics and Antengene Corporation announced their entry into an exclusive license agreement for the development and commercialization of four of Karyopharm's novel, oral drug candidates, including selinexor, Karyopharm's lead SINE compound, eltanexor, Karyopharm's second-generation SINE compound, verdinexor, Karyopharm's lead compound in development for viral and other non-oncology indications, and KPT-9274, Karyopharm's dual inhibitor of PAK4 and NAMPT.
demonstrated that PPAR[gamma] is involved in radiation-induced epithelial-to-mesenchymal transition (EMT) in glioma by interacting with p21-activated kinase 4 (PAK4), resulting in increased Nox1 expression and reactive oxygen species (ROS) [72].
Banasavadi-Siddegowda et al., "A novel interaction of PAK4 with PPARy to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma," Oncogene, vol.
Tenders are invited for Pak4 provoding and fixing mini high mast at ward no:11 Savalhall Tanda, ward no: 12 Jallihall Tanda & ward no: 13 Dr B.R.Ambedkar Nagar in Basavan Bagewadi Town
These are the EphA2 null mouse [101] and PAK4 null mouse [100].
Ryu et al., "Repositioning potential of pak4 to osteoclastic bone resorption," Journal of Bone and Mineral Research, vol.
In the postinfarct heart, miR-24 enhances survival, proliferation, and angiogenic function of EC by targeting GATA2, p21-activated kinase PAK4, and eNOS.
Inhibition of endothelial miR-24 significantly reduced myocardial infarct size via prevention of endothelial apoptosis and enhancement of vascularity after AMI through targeting of the endothelium-enriched transcription factor GATA2 and the p21-activated kinase 4 (PAK4), which led to preserved cardiac function and was closely related to HF [82].
PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/Erk-dependent pathways.
Here neurologists and other biomedical researchers explain in some detail how PAKs--particularly the oncogenic kinases PAK1 and PAK4 and their blockers--may control various aspects of life and health, and how mammalian PAKs have functionally evolved from their ancestral origins in unicellular organisms such as yeast and amoebas through a series of mutations over millions of years.
Se detectaron frecuentes mutaciones no descritas en la via de PI3K o en otras vias de kinasas, por ejemplo, en los tres genes que codifican los componentes de la va PI3K/Akt (PDK1, AKT2 y kinasa activada por p21 (PAK4)) en cancer colorrectal.